The antidiabetic effect of ginsenoside Rb2 via activation of AMPK
- PMID: 21811928
- DOI: 10.1007/s12272-011-0719-6
The antidiabetic effect of ginsenoside Rb2 via activation of AMPK
Abstract
Ginsenosides, which are active compounds found in ginseng (Panax ginseng), are used as antidiabetic treatments. The aim of this study was to determine whether Rb2, a type of ginsenoside, regulates hepatic gluconeogenesis through AMP-activated protein kinase (AMPK) and the orphan nuclear receptor small heterodimer partner (SHP) in hyperlipidemic conditions used as an in vitro model of type 2 diabetes. Considering these results, we concluded that Rb2 may inhibit palmitate-induced gluconeogenesis via AMPK-induced SHP by relieving ER stress, a cause of gluconeogenesis.
Comment in
-
AMP-activated protein kinase: a potential target for ginsenosides?Arch Pharm Res. 2011 Jul;34(7):1037-40. doi: 10.1007/s12272-011-0700-4. Arch Pharm Res. 2011. PMID: 21811908
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
